Largest pharmaceutical companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Johnson & Johnson leads the 61 pharmaceutical companies ranked by cash on hand, at SGD 25.4B, ahead of Merck & Co (SGD 18.8B) and Novartis (SGD 14.7B). Figures as of 18 Nov 2026, 23:02 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonSGD 25.4B
- Median
- SGD 739M
- Combined market value
- SGD 6.52T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Cash on hand ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | SGD 25.4B | SGD 846.2B | SGD 351.53 | 2.15% down | 38% up | ||
| 2 | Merck & CoMRK · Health Care | SGD 18.8B | SGD 437.8B | SGD 177.61 | 3.90% down | 51% up | ||
| 3 | NovartisNVS · Health Care | SGD 14.7B | SGD 377.9B | SGD 200.08 | 2.46% down | 25% up | ||
| 4 | Bristol-Myers SquibbBMY · Health Care | SGD 13.2B | SGD 156.9B | SGD 76.78 | 2.92% down | 34% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | SGD 11B | SGD 233.3B | SGD 134.68 | 0.22% down | 17% down | ||
| 6 | SanofiSNY · Health Care | SGD 11B | SGD 145.9B | SGD 60.74 | 0.86% down | 4% down | ||
| 7 | Eli LillyLLY · Health Care | SGD 9.4B | SGD 1.59T | SGD 1,782.46 | 2.32% down | 35% up | ||
| 8 | AstraZenecaAZN · Health Care | SGD 7.4B | SGD 357.4B | SGD 230.43 | 1.93% down | 2% up | ||
| 9 | AbbVieABBV · Health Care | SGD 6.7B | SGD 651.7B | SGD 368.69 | 2.33% down | 26% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | SGD 6.6B | SGD 175.3B | SGD 691.52 | 0.42% up | 27% up | ||
| 11 | BeOne MedicinesONC · Health Care | SGD 5.9B | SGD 59.4B | SGD 520.27 | 2.34% down | 17% up | ||
| 12 | GSKGSK · Health Care | SGD 5.8B | SGD 125.5B | SGD 62.62 | 1.34% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | SGD 5.1B | SGD 224B | SGD 50.83 | 3.12% down | 17% down | ||
| 14 | Takeda PharmaceuticalTAK · Health Care | SGD 4.8B | SGD 87.6B | SGD 27.42 | 1.71% down | 54% up | ||
| 15 | Teva Pharmaceutical IndustriesTEVA · Health Care | SGD 4.6B | SGD 63.5B | SGD 54.44 | 0.92% down | 74% up | ||
| 16 | Regeneron PharmaceuticalsREGN · Health Care | SGD 4B | SGD 126.1B | SGD 1,218.85 | 1.28% down | 36% up | ||
| 17 | ZoetisZTS · Health Care | SGD 3B | SGD 44.8B | SGD 110.31 | 2.50% up | 29% down | ||
| 18 | GenmabGMAB · Health Care | SGD 2.2B | SGD 40.5B | SGD 65.70 | 1.91% down | 70% up | ||
| 19 | Alnylam PharmaceuticalsALNY · Health Care | SGD 2.1B | SGD 25.8B | SGD 192.59 | 4.54% down | 66% down | ||
| 20 | United TherapeuticsUTHR · Health Care | SGD 2B | SGD 31.7B | SGD 744.23 | 1.16% down | 23% up | ||
| 21 | Roivant SciencesROIV · Health Care | SGD 1.8B | SGD 36.2B | SGD 49.93 | 0.05% up | 90% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | SGD 1.8B | SGD 20.5B | SGD 319.39 | 2.93% up | 37% up | ||
| 23 | ViatrisVTRS · Health Care | SGD 1.7B | SGD 30B | SGD 26.14 | 0.83% down | 96% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | SGD 1.7B | SGD 15.3B | SGD 79.19 | 4.99% up | 11% up | ||
| 25 | PfizerPFE · Health Care | SGD 1.5B | SGD 206.2B | SGD 36.17 | 1.44% down | 14% up | ||
| 26 | PTC TherapeuticsPTCT · Health Care | SGD 1.3B | SGD 6.5B | SGD 77.64 | 0.22% down | 20% down | ||
| 27 | GrifolsGRFS · Health Care | SGD 1.2B | SGD 7.4B | SGD 10.92 | 1.85% down | 1% up | ||
| 28 | Legend BiotechLEGN · Health Care | SGD 1.2B | SGD 4.1B | SGD 20.95 | 0.87% up | 42% down | ||
| 29 | Ascendis PharmaASND · Health Care | SGD 881.1M | SGD 22.9B | SGD 348.47 | 0.32% down | 28% up | ||
| 30 | Royalty PharmaRPRX · Health Care | SGD 797.5M | SGD 50.9B | SGD 88.52 | 0.01% down | 78% up | ||
| 31 | ABIVAXABVX · Health Care | SGD 739M | SGD 9.5B | SGD 108.06 | 2.11% up | 27% down | ||
| 32 | BridgeBio PharmaBBIO · Health Care | SGD 734.9M | SGD 19.6B | SGD 100.56 | 1.58% up | 17% up | ||
| 33 | Elanco Animal HealthELAN · Health Care | SGD 702.5M | SGD 17.2B | SGD 34.42 | 3.29% up | 20% up | ||
| 34 | InsmedINSM · Health Care | SGD 658M | SGD 33.9B | SGD 154.43 | 1.69% down | 40% down | ||
| 35 | AlkermesALKS · Health Care | SGD 500.9M | SGD 10.1B | SGD 60.39 | 3.08% up | 58% up | ||
| 36 | Ionis PharmaceuticalsIONS · Health Care | SGD 479.9M | SGD 5.9B | SGD 35.31 | 1.59% up | 64% down | ||
| 37 | Praxis Precision MedicinesPRAX · Health Care | SGD 460.6M | SGD 11B | SGD 393.41 | 0.04% up | 61% up | ||
| 38 | Belite BioBLTE · Health Care | SGD 455M | SGD 8.2B | SGD 201.39 | 0.94% down | 31% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | SGD 416.3M | SGD 9.1B | SGD 172.74 | 1.43% down | 7% down | ||
| 40 | Cogent BiosciencesCOGT · Health Care | SGD 402.2M | SGD 6.2B | SGD 35.85 | 0.14% down | 20% down | ||
| 41 | Mirum PharmaceuticalsMIRM · Health Care | SGD 382.4M | SGD 7.8B | SGD 119.23 | 0.59% up | 31% up | ||
| 42 | Amneal PharmaceuticalsAMRX · Health Care | SGD 363.6M | SGD 9.8B | SGD 28.20 | 3.60% up | 83% up | ||
| 43 | Definium TherapeuticsDFTX · Health Care | SGD 332.4M | SGD 5.1B | SGD 37.54 | 0.88% down | 169% up | ||
| 44 | Arrowhead PharmaceuticalsARWR · Health Care | SGD 292M | SGD 7.9B | SGD 55.57 | 0.28% up | 10% up | ||
| 45 | Summit TherapeuticsSMMT · Health Care | SGD 290.4M | SGD 10.8B | SGD 13.54 | 1.59% down | 36% down | ||
| 46 | Madrigal PharmaceuticalsMDGL · Health Care | SGD 256.1M | SGD 11.9B | SGD 513.15 | 5.67% down | 24% down | ||
| 47 | Ligand PharmaceuticalsLGND · Health Care | SGD 225.5M | SGD 7.7B | SGD 385.06 | 1.67% up | 43% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SGD 213.5M | SGD 9.6B | SGD 122.53 | 0.06% down | 126% up | ||
| 49 | Dr. Reddy's LaboratoriesRDY · Health Care | SGD 210.8M | SGD 16.1B | SGD 19.31 | 1.28% up | 5% up | ||
| 50 | Protagonist TherapeuticsPTGX · Health Care | SGD 165.5M | SGD 10.7B | SGD 163.92 | 2.00% up | 46% up | ||
| 51 | CytokineticsCYTK · Health Care | SGD 157.9M | SGD 9.2B | SGD 66.16 | 0.64% down | 20% down | ||
| 52 | Corcept TherapeuticsCORT · Health Care | SGD 155.3M | SGD 9.6B | SGD 87.39 | 3.25% down | 8% down | ||
| 53 | Travere TherapeuticsTVTX · Health Care | SGD 119.9M | SGD 6.2B | SGD 64.76 | 1.68% down | 44% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | SGD 110.5M | SGD 12.4B | SGD 130.79 | 8.15% up | 286% up | ||
| 55 | TG TherapeuticsTGTX · Health Care | SGD 102M | SGD 12.9B | SGD 85.23 | 5.44% up | 107% up | ||
| 56 | ErascaERAS · Health Care | SGD 95.1M | SGD 6.2B | SGD 17.74 | 0.94% down | 403% up | ||
| 57 | Edgewise TherapeuticsEWTX · Health Care | SGD 78.8M | SGD 5.8B | SGD 53.33 | 1.59% down | 88% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | SGD 70M | SGD 10.6B | SGD 153.45 | 2.08% up | 13% up | ||
| 59 | Dianthus TherapeuticsDNTH · Health Care | SGD 65.9M | SGD 6.1B | SGD 108.26 | 3.45% down | 113% up | ||
| 60 | Oruka TherapeuticsORKA · Health Care | SGD 60.5M | SGD 8.4B | SGD 123.42 | 0.60% down | 241% up | ||
| 61 | VeradermicsMANE · Health Care | SGD 28.1M | SGD 6.8B | SGD 160.95 | 0.62% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2891 SGD).
Questions and answers
Which pharmaceutical companies rank first by cash on hand?
Johnson & Johnson (SGD 25.4B), Merck & Co (SGD 18.8B) and Novartis (SGD 14.7B) are the top three of the 61 pharmaceutical companies ranked by cash on hand as of 18 Nov 2026, 23:02 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by cash on hand.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by cash on hand have a combined market value of SGD 6.52T as of 18 Nov 2026, 23:02 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.